Singer Douglas Mark 13D and 13G filings for Interpace Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 10:49 am Sale |
2025-01-10 | 13G | Interpace Biosciences, Inc. IDXG |
Singer Douglas Mark | 195,742 4.440% |
-31,304 (-13.79%) |
Filing |
| 2025-02-14 10:46 am Sale |
2024-12-31 | 13G | Interpace Biosciences, Inc. IDXG |
Singer Douglas Mark | 227,046 5.150% |
-22,954 (-9.18%) |
Filing |
| 2024-02-12 5:01 pm Sale |
2023-12-31 | 13G | Interpace Biosciences, Inc. IDXG |
Singer Douglas Mark | 250,000 5.780% |
-105,165 (-29.61%) |
Filing |
| 2023-02-10 4:23 pm Purchase |
2022-12-31 | 13G | Interpace Biosciences, Inc. IDXG |
Singer Douglas Mark | 355,165 8.320% |
62,165 (+21.22%) |
Filing |
| 2022-02-10 5:14 pm Purchase |
2022-01-31 | 13G | Interpace Biosciences, Inc. IDXG |
Singer Douglas Mark | 293,000 6.980% |
293,000 (New Position) |
Filing |